AF and Heart Failure.
Two conditions that are likely to dominate the next 50 years of cardiovascular care are also increasing in prevalence.
Both affect millions of people and after age 40:
1 in 4 people will develop AF
1 in 5 people will develop HF
And, regardless of which comes first - patients with AF and HF together have significantly worse prognosis.
Learn more about the impact of heart failure and AF: <a href="https://okt.to/ALk5Hv" target="_blank">https://okt.to/ALk5Hv</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=HeartFailure&highlighte…; target='_blank'>#HeartFailure</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>
-
Healthcare Professionals
-
Therapies and Procedures
-
Concomitant Surgical Ablation Therapy
- Ablation Sensing Unit & Switch Matrix
- cryoFORM® Cryoablation Probe
- cryoICE® BOX V6
- cryoICE® Cryoablation Probes
- Isolator® Linear Pen
- Isolator® Synergy™ Access® Clamp
- Isolator® Synergy™ Clamps (OLL2/OSL2)
- Isolator® Transpolar Pen (MAX3)
- Isolator® Synergy™ EnCompass® Clamp
- Multifunctional Ablation Generator (MAG)
- Hybrid AF™ Therapy
- Hybrid Total Thoracoscopic Therapy
- Left Atrial Appendage Management
- Cryo Nerve Block Therapy
-
Concomitant Surgical Ablation Therapy
- Education & Training
- Clinical Evidence
- Product Labeling
- Resources
- Society Guidelines
-
Therapies and Procedures
- Patients & Caregivers
- About AtriCure
